# Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump

> **NCT04409587** · PHASE4 · COMPLETED · sponsor: **Mountain Diabetes and Endocrine Center** · enrollment: 59 (actual)

## Conditions studied

- Type1 Diabetes Mellitus

## Interventions

- **DRUG:** Aspart

## Key facts

- **NCT ID:** NCT04409587
- **Lead sponsor:** Mountain Diabetes and Endocrine Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-12
- **Primary completion:** 2020-05-16
- **Final completion:** 2020-11-01
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2021-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04409587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04409587, "Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04409587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*